Ερευνητικό υλικό ΕΚΠΑ

Pathogen-driven treatment strategy in new onset dilated cardiomyopathy. Impact on ventricular function and clinical outcome

Αγγλικά

Δεν υπάρχει περίληψη

2016

Gkouziouta, A.
Lazaros, G.
Karavidas, A.
Georgiopoulos, G.
Miliopoulos, D.
Karavolias, G.
Pantou, M.
Hatzianastasiou, S.
Saroglou, G.
Voudris, V.
Adamopoulos, S.

International Journal of Cardiology

Elsevier Ireland Ltd

209

15-16

aciclovir; doxycycline; valganciclovir; antiinfective agent, adult; Article; chlamydiasis; clinical effectiveness; congestive cardiomyopathy; controlled study; cytomegalovirus infection; Epstein Barr virus infection; female; heart left ventricle ejection fraction; heart ventricle function; human; major clinical study; male; outcome assessment; priority journal; tertiary care center; Cardiomyopathy, Dilated; Chlamydia; drug effects; follow up; heart stroke volume; heart ventricle function; Human parvovirus B19; isolation and purification; microbiology; middle aged; physiology; prospective study; treatment outcome, Adult; Anti-Infective Agents; Cardiomyopathy, Dilated; Chlamydia; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parvovirus B19, Human; Prospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function

https://doi.org/10.1016/j.ijcard.2016.02.032

10.1016/j.ijcard.2016.02.032

https://pergamos.lib.uoa.gr/uoa/dl/object/3124459